Why the study?
Does acetazolamide stimulation allow assessment of cerebral vasomotor reactivity using combined diffuse optics-ultrasound technique in healthy volunteers?
Does acetazolamide stimulation allow assessment of cerebral vasomotor reactivity using combined diffuse optics-ultrasound technique in healthy volunteers?
A combined diffuse optics-ultrasound technique is a viable method to continuously monitor cerebral vasomotor reactivity and metabolic rate of oxygen at the bedside in real time.
Answers are grounded in this paper and cite their sources.
Supports bedside cerebral vasomotor reactivity monitoring with combined optics-ultrasound in volunteers; leaves open patient validation and clinical adoption.
Acetazolamide (ACZ) was used to stimulate the cerebral vasculature on ten healthy volunteers to assess the cerebral vasomotor reactivity (CVR). We have combined near infrared spectroscopy (NIRS), diffuse correlation spectroscopy (DCS) and transcranial Doppler (TCD) technologies to non-invasively assess CVR in real-time by measuring oxy- and deoxy-hemoglobin concentrations, using NIRS, local cerebral blood flow (CBF), using DCS, and blood flow velocity (CBFV) in the middle cerebral artery, using TCD. Robust and persistent increases in oxy-hemoglobin concentration, CBF and CBFV were observed. A significant agreement was found between macro-vascular (TCD) and micro-vascular (DCS) hemodynamics, between the NIRS and TCD data, and also within NIRS and DCS results. The relative cerebral metabolic rate of oxygen, rCMRO(2), was also determined, and no significant change was observed. Our results showed that the combined diffuse optics-ultrasound technique is viable to follow (CVR) and rCMRO(2) changes in adults, continuously, at the bed-side and in real time.
No takes yet. Share an insight, caveat, or question.
Zirak et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: